NCT00768664 2021-02-09
Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer
Pfizer
Phase 2 Completed
Clinical Trials
5 trialsNCT01737008 2016-06-13
Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck
University Health Network, Toronto
Phase 1 Completed
NCT01116843 2015-07-10
Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment
University Health Network, Toronto
Phase 1/2 Completed
NCT01484847 2015-07-10
A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma
University Health Network, Toronto
Phase NA Completed
NCT01449201 2014-09-30
PF-00299804 in Patients With Head and Neck Squamous Cell Carcinoma
Yonsei University
Phase 2 Completed